Sri Jayadeva Institute of Cardiovascular Sciences and Research, in collaboration with Medtronic and Govindaraju ... High-quality medicated imported stents will be given for free to all the patients.

This rate is the lowest recorded for any carotid stent or embolic protection device pivotal trial to date. The trial's findings were initially presented in May at the Leipzig Interventional Course ...

The C-GUARDIANS results showed a primary endpoint 1 major adverse event rate of 1.95% through twelve months post-procedure, the lowest such event rate reported for any carotid stent or embolic ...

TEL AVIV - InspireMD, Inc. (NASDAQ:NSPR), a medical device company, has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its CGuard Prime carotid ...

Donald Trump risks being doomed by what he wrought in North Carolina. An already fiercely fought presidential contest in the critical swing state was thrown into greater turmoil Thursday by a ...

The Medtronic Talent thoracic stent graft. The Medtronic Talent stent graft system consists of two components. The proximal stent graft device is a straight tubular endograft with proximal FreeFlo ...

The company designed the CGuard Prime carotid stent system for the treatment of carotid artery stenosis. It based its PMA ...

Inc., developer of the CGuard embolic prevention stent system for the prevention of stroke, announced that it has submitted a premarket approval (PMA) application to the FDA seeking marketing approval ...